Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emily Borushko"'
Autor:
Scott Miskevics, Emily Borushko, Michael J. Avram, D. James Surmeier, Aleksandar Videnovic, Cindy Zadikoff, Audrey Martel, Karen Williams, Frances M. Weaver, Tanya Simuni
Publikováno v:
Movement Disorders. 25:2863-2866
Recent data suggests that isradipine, a dihydropyridine calcium channel blocker, is neuroprotective in preclinical models of parkinsonism. Isradipine has not been systematically studied in patients with Parkinson's disease (PD). The aim of this study
Autor:
Aleksandar Videnovic, Cindy Zadikoff, Emily Borushko, Roneil G. Malkani, Onur Melen, Tanya Simuni
Publikováno v:
Clinical Neuropharmacology. 35:266-268
Background Freezing of gait (FOG) is a common symptom in patients with advanced Parkinson's disease (PD) representing a major cause of disability and falls. Although the pathophysiology of FOG remains poorly understood, nondopaminergic pathways have
Autor:
Anna Hohler, Rachel Saunders-Pullman, Robert A. Hauser, M.B. Stern, Liza Reys, Valerie Iannucci, Maria R. Albelo, Danna Jennings, Donna Miles, Emily Borushko, Linda McGinn, Irene H. Richard, Jacqueline Rick, Grace S. Liang, Indu Subramanian, Abby Fiocco, Cheryl Deely, Kapil D. Sethi, Angelina Gratiano, Amy Duffy, Matthew B. Stern, Shirley Lasch, Kathryn A. Chung, Andrew Siderowf, Keith A. Hawkins, Shirley Eberly, Cathi A. Thomas, Shawna Johnson, Eugene Lai, Marian L. Evatt, Kenneth Marek, Albert Ascherio, Leyla Khavarian, Emily Virden, Candace Cotto, Brenna M. Lobb, Farah Atassi, Paula Jackson, Brian Howard, Susan O'Conner, Carolyn Cioffi, Michael E. DeBakey, Charles H. Adler, Theresa McClain, Tanya Simuni, Samuel Frank, David W. Russell, David Oakes, Katrina Miles, Allison Gadoury, Gary Wisniewski, Susan Mendick, Raymond C. James
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 27(3)
To test the association between impaired olfaction and other prodromal features of PD in the Parkinson At-Risk Syndrome Study. The onset of olfactory dysfunction in PD typically precedes motor features, suggesting that olfactory testing could be used
Autor:
Tanya, Simuni, Emily, Borushko, Michael J, Avram, Scott, Miskevics, Audrey, Martel, C, Zadikoff, Aleksandar, Videnovic, Frances M, Weaver, Karen, Williams, D James, Surmeier
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 25(16)
Recent data suggests that isradipine, a dihydropyridine calcium channel blocker, is neuroprotective in preclinical models of parkinsonism. Isradipine has not been systematically studied in patients with Parkinson's disease (PD). The aim of this study